ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ATHX Athersys Inc

0.1018
0.00 (0.00%)
Pre Market
Last Updated: 10:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Athersys Inc ATHX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 0.1018 10:00:00
Open Price Low Price High Price Close Price Previous Close
0.1018
more quote information »

Recent News

Date Time Source Heading
08/1/202423:31EDGAR2Form 8-K - Current report
23/12/202309:09EDGAR2Form 8-K - Current report
22/12/202303:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202300:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
18/10/202323:00EDGAR2Form 8-K - Current report
17/10/202307:52BWAthersys Extends Near Term Liquidity with Proceeds from..
13/10/202300:28EDGAR2Form 8-K - Current report
12/10/202300:27EDGAR2Form 8-K - Current report
10/10/202323:30BWAthersys Reports Interim Analysis Results of MASTERS-2..
07/10/202308:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/10/202308:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202307:41EDGAR2Form 8-K - Current report
04/10/202307:30BWAthersys Licenses its Animal Health Assets to Ardent Animal..
03/10/202308:05EDGAR2Form 8-K - Current report
03/10/202308:04BWAthersys Director Jane Wasman Appointed Board Chair
26/9/202306:36EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
22/9/202314:15EDGAR2Form EFFECT - Notice of Effectiveness
20/9/202302:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/9/202311:35EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
19/9/202311:04EDGAR2Form 8-K - Current report
15/9/202301:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/9/202300:41EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/9/202307:13EDGAR2Form S-3 - Registration statement under Securities Act of..
11/9/202322:46EDGAR2Form 8-K - Current report
07/9/202304:45BWGrant Awarded to Newcastle University to Research Athersys’..
22/8/202304:36EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
19/8/202300:14EDGAR2Form 8-K - Current report
18/8/202311:30BWAthersys, Inc. Announces Pricing of $3.5 Million Public..
18/8/202306:15EDGAR2Form DEF 14A - Other definitive proxy statements
17/8/202307:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
17/8/202307:01BWAthersys Reports Second Quarter 2023 Financial Results and..
11/8/202322:19EDGAR2Form 8-K - Current report
11/8/202322:00BWAthersys Appoints Neema Mayhugh, PhD to its Board of..
11/8/202307:03EDGAR2Form 8-K - Current report
08/8/202322:02EDGAR2Form 8-K - Current report
08/8/202307:02EDGAR2Form S-1/A - General form for registration of securities..
01/8/202303:38BWAthersys to Host Business Update Conference Call on August..
31/7/202322:01EDGAR2Form 8-K - Current report
26/7/202323:19EDGAR2Form S-1/A - General form for registration of securities..
15/7/202306:31EDGAR2Form S-1 - General form for registration of securities under..
15/7/202306:16EDGAR2Form 8-K/A - Current report: [Amend]
06/7/202323:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/7/202323:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/7/202304:04EDGAR2Form 8-K - Current report
02/6/202306:40BWPatient Enrollment Begins in Third and Final Cohort of the..
23/5/202322:30BWAthersys Restructures Debt with Supplier
18/5/202323:58BWAthersys Reports First Quarter 2023 Financial Results and..
08/5/202323:49BWAthersys to Participate in Three Upcoming Conferences
01/5/202322:30BWAthersys to Participate in The Cellular Therapies and..
22/4/202304:23BWAthersys to Participate in The American Society for Neural..

Your Recent History

Delayed Upgrade Clock